Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma.
作者信息
Marek Andrew J, Ming Michael E, Bartlett Edmund K, Karakousis Giorgos C, Chu Emily Y
机构信息
Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
出版信息
JAMA Dermatol. 2016 Jul 1;152(7):836-7. doi: 10.1001/jamadermatol.2016.0875.
Abstract
摘要
相似文献
1
Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma.肢端雀斑样组织学亚型与薄型黑色素瘤前哨淋巴结阳性情况
JAMA Dermatol. 2016 Jul 1;152(7):836-7. doi: 10.1001/jamadermatol.2016.0875.
2
Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.与侵袭性黑色素瘤活检深度横切相关的临床和病理因素。
J Am Acad Dermatol. 2017 Oct;77(4):766-768. doi: 10.1016/j.jaad.2017.04.1134.
3
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?T1期（薄型）黑色素瘤的前哨淋巴结活检：有必要吗？
Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E.
4
The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.前哨淋巴结活检时间对皮肤黑色素瘤生存的影响。
Am J Surg. 2016 Nov;212(5):935-940. doi: 10.1016/j.amjsurg.2016.02.025. Epub 2016 May 12.
5
Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.与前哨淋巴结阳性的黑色素瘤患者相比，前哨淋巴结活检阴性的复发性黑色素瘤患者预后更差。
Eur J Surg Oncol. 2016 Sep;42(9):1420-6. doi: 10.1016/j.ejso.2016.03.038. Epub 2016 Apr 19.
6
Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma.薄型黑色素瘤中肿瘤浸润淋巴细胞与前哨淋巴结阳性之间的关联
An Bras Dermatol. 2019 Jan-Feb;94(1):47-51. doi: 10.1590/abd1806-4841.20197414.
7
Cutaneous Squamous Cell Carcinoma Tumour Size is Associated with Sentinel Lymph Node Metastasis in a Cohort of 69 Patients.69 例患者队列中，皮肤鳞状细胞癌肿瘤大小与前哨淋巴结转移相关。
Acta Derm Venereol. 2019 Dec 1;99(13):1241-1245. doi: 10.2340/00015555-3293.
8
Probability of sentinel lymph node positivity in melanoma.黑色素瘤前哨淋巴结阳性的概率。
Eur J Cancer. 2019 Jul;116:10-12. doi: 10.1016/j.ejca.2019.04.034. Epub 2019 Jun 1.
9
The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.原发性黑色素瘤切除与前哨淋巴结活检之间的间隔时间与前哨淋巴结阳性患者的生存率无关——一项欧洲癌症研究与治疗组织黑色素瘤协作组的研究。
Eur J Surg Oncol. 2016 Dec;42(12):1906-1913. doi: 10.1016/j.ejso.2016.05.012. Epub 2016 May 27.
10
A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.回顾性、多中心分析有丝分裂率对薄型黑色素瘤前哨淋巴结 (SLN) 阳性的预测价值。
J Am Acad Dermatol. 2016 Jan;74(1):94-101. doi: 10.1016/j.jaad.2015.09.014. Epub 2015 Nov 2.
引用本文的文献
1
Influence of sentinel lymph node biopsy on the prognosis of acral melanoma patients.前哨淋巴结活检对肢端黑色素瘤患者预后的影响。
An Bras Dermatol. 2025 Jun 18;100(4):501129. doi: 10.1016/j.abd.2025.501129.
2
Evaluation of Demographic and Clinical Characteristics of Turkish Patients With Primary Cutaneous Melanoma: A 5-Year Experience of a Tertiary Referral Center.土耳其原发性皮肤黑色素瘤患者的人口统计学和临床特征评估：一家三级转诊中心的5年经验
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024135. doi: 10.5826/dpc.1403a135.
3
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial.尼罗替尼治疗 KIT 驱动的晚期黑色素瘤：来自 II 期单臂 NICAM 试验的结果。
Cell Rep Med. 2024 Mar 19;5(3):101435. doi: 10.1016/j.xcrm.2024.101435. Epub 2024 Feb 27.
4
Recent advancements in the diagnosis and treatment of acral melanoma.肢端黑色素瘤的诊断和治疗新进展。
J Zhejiang Univ Sci B. 2024 Feb 15;25(2):106-122. doi: 10.1631/jzus.B2300221.
5
Acral Lentiginous Melanoma: Do Surgical Approach and Sentinel Lymph Node Biopsy Matter?肢端雀斑样痣黑色素瘤：手术方式和前哨淋巴结活检重要吗？
Plast Reconstr Surg Glob Open. 2020 Mar 25;8(3):e2698. doi: 10.1097/GOX.0000000000002698. eCollection 2020 Mar.
6
Current management of regional lymph nodes in patients with melanoma.黑色素瘤患者区域淋巴结的当前管理
J Surg Oncol. 2019 Jan;119(2):200-207. doi: 10.1002/jso.25316. Epub 2018 Nov 27.
7
Diagnosis and Management of Acral Lentiginous Melanoma.肢端雀斑样黑素瘤的诊断与治疗。
Curr Treat Options Oncol. 2018 Jun 27;19(8):42. doi: 10.1007/s11864-018-0560-y.
本文引用的文献
1
More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia.在澳大利亚昆士兰州，死于薄型黑色素瘤（厚度≤1毫米）的人数比死于厚型黑色素瘤（厚度>4毫米）的人数更多。
J Invest Dermatol. 2015 Apr;135(4):1190-1193. doi: 10.1038/jid.2014.452. Epub 2014 Oct 20.
2
Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.Clark 分级风险分层有丝分裂性薄型黑色素瘤患者行前哨淋巴结活检。
Ann Surg Oncol. 2014 Feb;21(2):643-9. doi: 10.1245/s10434-013-3313-y. Epub 2013 Oct 12.
3
Melanoma thickness trends in the United States, 1988-2006.美国 1988-2006 年黑色素瘤厚度趋势。
J Invest Dermatol. 2010 Mar;130(3):793-7. doi: 10.1038/jid.2009.328. Epub 2009 Oct 15.
4
Importance of sentinel lymph node biopsy in patients with thin melanoma.前哨淋巴结活检在薄型黑色素瘤患者中的重要性。
Arch Surg. 2008 Sep;143(9):892-9; discussion 899-900. doi: 10.1001/archsurg.143.9.892.
5
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.区域淋巴结转移疾病是薄垂直生长期黑色素瘤患者生存的最强预测指标：这些患者应行前哨淋巴结分期活检。
Ann Surg Oncol. 2007 May;14(5):1596-603. doi: 10.1245/s10434-006-9319-y. Epub 2007 Feb 7.
Zotero 插件